Cargando…
Pharmacokinetics and pharmacodynamics of growth hormone in patients on chronic haemodialysis compared with matched healthy subjects: an open, nonrandomized, parallel-group trial
BACKGROUND: GH may be beneficial in treating patients with end-stage renal disease (ESRD). However, the efficacy and safety of GH could be compromised by the potential for accumulation in the circulation. OBJECTIVE: The objective was to investigate the pharmacokinetics and safety of GH treatment in...
Autores principales: | Langbakke, Irene H, Nielsen, Jakob N, Skettrup, Mia P, Harper, Angela, Klitgaard, Thomas, Weil, Angelika, Engelhardt, Eva, Lange, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366021/ https://www.ncbi.nlm.nih.gov/pubmed/17634080 http://dx.doi.org/10.1111/j.1365-2265.2007.02962.x |
Ejemplares similares
-
Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic‐pharmacodynamic analysis of cinacalcet
por: Chen, Ping, et al.
Publicado: (2019) -
Pharmacokinetic/pharmacodynamic profiling of imipenem in patients admitted to an intensive care unit in India: A nonrandomized, cross-sectional, analytical, open-labeled study
por: Abhilash, B., et al.
Publicado: (2015) -
Drug therapy for adenomyosis: a prospective, nonrandomized, parallel-controlled study
por: Li, Qing, et al.
Publicado: (2018) -
Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020) -
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
por: McCarthy, Matthew William
Publicado: (2021)